financial results

Chinese insurtech leader $YB reports 33% revenue growth and 51% net income surge for fiscal 2025, bolstered by AI capabilities and user expansion.

$GEMI reschedules fourth quarter 2025 earnings conference call to March 20, pushing results release to March 19 after-hours.

Pomerantz LLP investigates $SNAP over disappointing Q2 results, weak guidance, and child safety lawsuit, as stock plunges 26.9%.

TON Strategy Company schedules March 31, 2026 earnings call to report 2025 results as digital asset treasury continues expanding Toncoin holdings.

Neumora Therapeutics will report 2025 financial results March 30, 2026, with major KOASTAL trial readouts anticipated in Q2 2026.

Class action lawsuit filed against $CWH over false inventory and demand statements. Stock fell 25% post-Q3, another 16% after Q4 results revealed inventory corrections and dividend suspension.

$SAMG will discuss full-year 2025 earnings on March 17, 2026, with leadership highlighting performance across its wealth management platform.

$STRR reports Q4 2025 earnings on March 17, following August acquisition of Star Operating Companies and September ticker change.

Microvast will release full-year 2025 earnings on March 16, 2026, followed by investor conference call at 4:00 p.m. Central Time.

SCOR reports €851M net income for 2025, €208M in Q4; proposes €1.9 dividend per share following strong reinsurance performance.

SCOR SE filed its 2025 Universal Registration Document, reporting €851M annual net income and €18.7B in premiums, with a €1.9 per-share dividend proposed.

Class action lawsuit filed against $CWH for allegedly making false statements about business operations. Stock fell 24.8% and 16.5% in two separate drops.

Westport Fuel Systems reports 2025 results March 26, 2026, as hydrogen manufacturing capacity ramps following $6.5M divestiture proceeds.

Vuzix reported 2025 results with $6.3M revenue, $32.3M net loss (vs. $73.5M prior year), and secured $20M Quanta investment by hitting production targets.

Molecular Partners reports CHF 61.7M net loss but maintains CHF 93.1M cash runway through 2028, advancing Radio-DARPin and immuno-oncology pipeline programs.

Distribution Solutions Group faces securities fraud probe after March earnings miss triggered 26.3% stock plunge to $21.90, amid end-market softness and cost pressures.

$BUDA to report FY2025 earnings March 26, 2026, revealing UltraFresh juice category traction and financial health for investors tracking premium beverage innovation.

Here Group reports Q2 FY2026 revenues of $25.3M, up 39.4% QoQ, while managing losses through cost optimization and offline expansion.

Futu Holdings reports doubled net income to HK$11.3B in 2025 with 68% revenue growth, adding nearly 1M funded accounts across Asia.

Law firm investigates $DSGR for potential securities fraud following March earnings miss that triggered 26.3% stock decline to $21.90.